USD1014246S1 - External medication packaging - Google Patents

External medication packaging Download PDF

Info

Publication number
USD1014246S1
USD1014246S1 US29/820,181 US202129820181F USD1014246S US D1014246 S1 USD1014246 S1 US D1014246S1 US 202129820181 F US202129820181 F US 202129820181F US D1014246 S USD1014246 S US D1014246S
Authority
US
United States
Prior art keywords
medication packaging
external medication
view
external
packaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
US29/820,181
Inventor
Merle Lee
Anthony Mazza
Andrew Ruocco
Kari Peterson
Hetal Naik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Priority to US29/820,181 priority Critical patent/USD1014246S1/en
Priority to JP2022502613F priority patent/JP1762619S/en
Assigned to PFIZER INC. reassignment PFIZER INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: PETERSON, KARI, RUOCCO, ANDREW, MAZZA, ANTHONY, LEE, MERLE, NAIK, Hetal
Application granted granted Critical
Publication of USD1014246S1 publication Critical patent/USD1014246S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

FIG. 1 is a top perspective view for an external medication packaging.
FIG. 2 is a back side view thereof;
FIG. 3 is a front side view thereof;
FIG. 4 is a right side view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a bottom view thereof;
FIG. 7 is a top view thereof;
FIG. 8 is a top perspective view, shown in an open state; and,
FIG. 9 is a top perspective view thereof, shown with exemplary blister packages.
The broken lines in the drawings represent unclaimed subject matter and form no part of the claim.
The evenly broken lines are shown for the purpose of illustrating environmental subject matter of exemplary blister packages and form no part of the claimed design.
The heavy oval dashed lines shown on the top surface of FIGS. 1, 7, 8 and 9 represent perforations that form part of the claimed design.

Claims (1)

    CLAIM
  1. The ornamental design for an external medication packaging, as shown and described.
US29/820,181 2021-12-20 2021-12-20 External medication packaging Active USD1014246S1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US29/820,181 USD1014246S1 (en) 2021-12-20 2021-12-20 External medication packaging
JP2022502613F JP1762619S (en) 2021-12-20 2022-06-17 Pharmaceutical packaging box

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/820,181 USD1014246S1 (en) 2021-12-20 2021-12-20 External medication packaging

Publications (1)

Publication Number Publication Date
USD1014246S1 true USD1014246S1 (en) 2024-02-13

Family

ID=89704613

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/820,181 Active USD1014246S1 (en) 2021-12-20 2021-12-20 External medication packaging

Country Status (2)

Country Link
US (1) USD1014246S1 (en)
JP (1) JP1762619S (en)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841874A1 (en) * 2002-07-03 2004-01-09 Smurfit Socar Sa Bottle packaging procedure uses semi-rigid container without spacers and applying pressure to ensure elimination of gaps between bottles
USD503614S1 (en) * 2002-10-17 2005-04-05 Stone Container Corporation Box convertible to a display container
DE202009007171U1 (en) * 2009-05-19 2009-08-20 Dürrwang, Helmut Pharmaceutical carton
USD707552S1 (en) * 2011-02-22 2014-06-24 Amorepacific Corporation Packing box
USD746677S1 (en) * 2014-07-02 2016-01-05 Pfizer Inc. Carton
USD756237S1 (en) * 2013-09-27 2016-05-17 Sata Gmbh & Co. Kg Package
USD842692S1 (en) * 2016-12-28 2019-03-12 Kimberly-Clark Worldwide, Inc. Package
USD843850S1 (en) * 2016-11-23 2019-03-26 Amicus Therapeutics, Inc. Drug package
USD874925S1 (en) * 2018-04-17 2020-02-11 ASSA ABLOY Branding Sàrl Package
USD904879S1 (en) * 2019-05-08 2020-12-15 Samsung Bioepis Co., Ltd. Box for packaging
RU216294U1 (en) * 2022-07-08 2023-01-26 Акционерное общество "БИОКАД" Pharmaceutical carton packaging

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2841874A1 (en) * 2002-07-03 2004-01-09 Smurfit Socar Sa Bottle packaging procedure uses semi-rigid container without spacers and applying pressure to ensure elimination of gaps between bottles
USD503614S1 (en) * 2002-10-17 2005-04-05 Stone Container Corporation Box convertible to a display container
DE202009007171U1 (en) * 2009-05-19 2009-08-20 Dürrwang, Helmut Pharmaceutical carton
USD707552S1 (en) * 2011-02-22 2014-06-24 Amorepacific Corporation Packing box
USD756237S1 (en) * 2013-09-27 2016-05-17 Sata Gmbh & Co. Kg Package
USD746677S1 (en) * 2014-07-02 2016-01-05 Pfizer Inc. Carton
USD843850S1 (en) * 2016-11-23 2019-03-26 Amicus Therapeutics, Inc. Drug package
USD842692S1 (en) * 2016-12-28 2019-03-12 Kimberly-Clark Worldwide, Inc. Package
USD874925S1 (en) * 2018-04-17 2020-02-11 ASSA ABLOY Branding Sàrl Package
USD904879S1 (en) * 2019-05-08 2020-12-15 Samsung Bioepis Co., Ltd. Box for packaging
RU216294U1 (en) * 2022-07-08 2023-01-26 Акционерное общество "БИОКАД" Pharmaceutical carton packaging

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"China approves use of Pfi zer's COVID drug Paxlovid," published in Reuters.com. Date published: Feb. 14, 2022. Site visited: Apr. 25, 2023. Available online: https://www.reuters.com/business/healthcare-pharmaceuticals/china-gives-conditional-approval-pfizers-covid-drug-paxlovid-2022-02-12/ (Year: 2022). *
"The Perfect Medicalpackaging? Clear, Simple Andtrusty!", in Packly Blog. Date published: Aug. 4, 2017. Site visited: Apr. 25, 2023. Available online: https://blog.pack.ly/en/medical-packaging-clear-design/ (Year: 2017). *
What is Paxlovid? How it treats COVID and who should take it—YouTube. Date posted: Aug. 2, 2022. Site visited: Apr. 25, 2023. Available online: https://www.youtube.com/watch?v=-VsV2pE5e3U (Year: 2022). *

Also Published As

Publication number Publication date
JP1762619S (en) 2024-01-30

Similar Documents

Publication Publication Date Title
USD946548S1 (en) Electronic device
USD946547S1 (en) Electronic device
USD962927S1 (en) Electronic device
USD971588S1 (en) Pill box
USD939350S1 (en) Bottle
USD968380S1 (en) Case for electronic device
USD1011893S1 (en) Container
USD912506S1 (en) Package
USD988137S1 (en) Container
USD977977S1 (en) Container
USD965575S1 (en) Case for electronic device
USD968378S1 (en) Case for electronic device
USD978140S1 (en) Electronic device
USD945313S1 (en) Buckle
USD1000897S1 (en) Container lid
USD965574S1 (en) Case for electronic device
USD961567S1 (en) Electronic device
USD963042S1 (en) Electronic device
USD970338S1 (en) Clamshell packaging container
USD971907S1 (en) Case for electronic device
USD965576S1 (en) Case for electronic device
USD968381S1 (en) Case for electronic device
USD941146S1 (en) Lid
USD929861S1 (en) Package
USD968379S1 (en) Case for electronic device

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO SMALL (ORIGINAL EVENT CODE: SMAL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY